|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
The goal of this study was to examine the mechanisms of leukotriene C4 (LTC4) synthase gene expression in mononuclear
phagocytes. Transfection of the monocyte-like cell line THP-1
with LTC4 synthase promoter-reporter constructs demonstrated that the first 1.3 kb of the promoter mediated a 21.1-fold increase in reporter activity. Deletion analysis revealed
that the region between
92 and
23 bp, which contains a
signal protein (Sp)1 consensus site at
42 to
37 bp, mediated an 11.5-fold increase in reporter activity. Using a probe
from
56 to
17 bp, electrophoretic mobility shift assays
(EMSAs) demonstrated that Sp1 and THP-1 and HeLa nuclear extracts bind to this region. Binding was eliminated by mutation of the Sp1 consensus site. Supershift EMSAs using anti-Sp1 and anti-Sp3 antibodies demonstrated that these Sp family members bind to the region. Transfection of the Sp-deficient Drosophila SL-2 cell line with a construct containing the
92 to
23 bp promoter region and Sp expression vectors revealed that Sp1 and Sp3 transactivate gene transcription. We
conclude that the Sp1 site is a necessary element for LTC4 synthase gene transcription. Sp1 and Sp3 function through this
site to positively regulate transcription. Thus, we provide evidence that the LTC4 synthase gene is transcriptionally regulated in mononuclear phagocytes.
| |
Introduction |
|---|
|
|
|---|
Leukotrienes are metabolites of arachidonic acid that are derived via the 5-lipoxygenase pathway. The formation of leukotriene (LT) C4 is the first committed step in the synthesis of the cysteinyl leukotrienes LTC4, LTD4, and LTE4. A large body of experimental evidence has demonstrated that the cysteinyl leukotrienes mediate a variety of inflammatory responses (1, 2). The role of these substances in inflammation strongly associates them in the pathogenesis of multiple inflammatory and allergic diseases (1, 3, 4).
LTC4 synthase (relative molecular mass of 16,568; EC#2.5.1.37) is a selective, membrane-bound glutathione-S-transferase that catalyzes the conversion of LTA4 to LTC4. The distribution of LTC4 synthase activity is restricted to eosinophils, basophils, mast cells, platelets, endothelial cells, and cells of monocyte/macrophage lineage. Recent studies also indicate the presence of a microsomal glutathione-S-transferase that possesses LTC4 synthase activity and shares structural homology with LTC4 synthase (5). Although the presence of microsomal glutathione-S-transferases in noninflammatory cells may account for LTC4 synthase activity in these tissues (6), the distribution of the LTC4 synthase enzyme appears to be limited to inflammatory cells (1). Studies suggest that LTC4 synthase expression is increased in the bronchial mucosa of patients with aspirin-sensitive asthma (7), and therefore, overexpression of this enzyme may play a role in this disease.
The gene for LTC4 synthase has been cloned, sequenced,
and mapped to the distal region of chromosome 5 (8, 9). The
LTC4 synthase 5' flanking region has been demonstrated to
possess putative binding sites for ets, activator protein
(AP)-1, AP-2, and signal protein (Sp)1 (8, 9) that may function as regulatory sequences. Previous studies suggest that
the LTC4 synthase enzyme may be phosphoregulated by
phorbol esters (10). In addition, reports suggest that enzyme activity is modulated by various cytokines, including interleukin (IL)-3, IL-5, and granulocyte-macrophage colony
stimulating factor (GM-CSF) (14, 15), in complex in vitro
conditioning experiments. Previous work from our laboratory indicates that LTC4 synthase gene expression is upregulated by transforming growth factor (TGF)-
through a transcriptional mechanism in the monocyte-like cell line THP-1
(16). However, the mechanism of cell-specific expression of
this enzyme has not been explored and the regulation of constitutive expression has not been previously reported.
The purpose of this study was to begin to investigate the molecular mechanisms of regulation of transcription of the LTC4 synthase gene in mononuclear phagocytes, a primary effector cell known to function in inflammatory disease. In this study, we report a functional analysis of the LTC4 synthase promoter. We also demonstrate evidence that the Sp family members play a critical role in the regulation of expression of the LTC4 synthase gene.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture
THP-1, HeLa, and Drosophila SL-2 cells were obtained from American Type Culture Collection (Manassas, VA). The monocyte-like cell line THP-1 has proven to be an effective model for the study of 5-lipoxygenase pathway regulation in previous studies from our laboratory (17). THP-1 cells were grown at 37°C with 5% CO2 in RPMI 1640 medium supplemented with 10% heat-treated fetal calf serum (FCS), 100 U/ml of penicillin, 100 µg/ml of streptomycin, and 100 µg/ml of gentamicin. HeLa cells were grown at 37°C with 5% CO2 in Eagle's minimum essential medium (MEM) supplemented with 10% FCS, 100 U/ml of penicillin, and 100 µg/ml of streptomycin. Drosophila SL-2 cells were grown at 25°C in Schneider's Drosophila medium with 10% FCS, 100 U/ml of penicillin, and 100 µg/ml of streptomycin. The media were changed every 2 d for all experiments. The cells were not conditioned or stimulated for any experimental protocols.
Screening of THP-1 and HeLa Cells for LTC4 Synthase Messenger RNA
Total RNA was extracted from THP-1 and HeLa cells by a previously described technique (18). Reverse transcriptase/polymerase chain reaction (RT-PCR) was performed on 5 µg of extracted total RNA using the Superscript II kit (GIBCO, Gaithersburg, MD) according to the manufacturer's instructions. A PCR was then performed to screen for LTC4 synthase complementary DNA (cDNA), as has been previously described (8). The forward primer was 5'-CCAGCTCGCCTTCACACACAG (from +33 to +53 bp, relative to the transcription start site) and the reverse primer was 5'-TTGCAGCAGGACTCCCAGGAG (from +135 to +115 bp) with an expected PCR product of 103 bp. Thirty cycles of PCR were performed, with each cycle consisting of denaturation at 94°C for 45 s, annealing at 60°C for 30 s, and extension at 72°C for 60 s. The PCR product was electrophoresed through an agarose gel and visualized by ethidium bromide staining.
Construction of the Luciferase Promoter-Reporter Constructs
A 1.3-kb fragment of the LTC4 synthase promoter (starting at
+119 bp relative to the transcription start site) was prepared by
PCR amplification from a human genomic DNA clone (8). The forward primer was 5'-GGCATATCTGGTTTCCGG (from
1,345 to
1,328 bp) and the reverse primer was 5'-TTGCAGCAGGACTCCCAGGAG (from +135 to +115 bp). The PCR
conditions were pH 9.0, 60 mM Tris-HCl, 15 mM (NH4)2SO4, and
2 mM MgCl2. Thirty cycles of PCR were performed, with each cycle consisting of denaturation at 94°C for 45 s, annealing at 55°C
for 30 s, and extension at 72°C for 60 s. The PCR product was
electrophoresed through a 1.2% agarose gel and visualized by
ethidium bromide staining. The product was isolated and ligated into a pGEM-T vector, and the sequence was confirmed by
dideoxy chain termination sequencing. Successive 5' deletions of
the LTC4 synthase promoter were accomplished using PCR performed on the above plasmid. The forward primers were 5'-GGCATATCTGGTTTCCGG (p[
1,345]LUC), 5'-GTGCTTCTGGGTCAGTCTGG (p[
1,157]LUC), 5'-GGATGGCCCACAAGGGCTGA (p[
624]LUC), 5'-CAGGGAACAGATAAGGTGG (p[
367]LUC), 5'-TGACCCAGATGGACAGCTTG (p[
239]LUC), 5-TGGCTCTGTGTGGTATG (p[
92]LUC), 5'-ACTGAGATGGGGCGGGGAGA (p[
51]LUC), and 5'-GCTGCTCTTCCTCTCCTG (p[
23]LUC). Because all the promoter
fragments shared a common 3' end at +119 bp (relative to the
transcription start site), the reverse primer was 5'-GACTCCCGGGAGGGTGACAGCA with a single base substitution introduced (G for A at the underlined site) to create a Sma1 site
within the primer. Thirty cycles of PCR were performed, with
each cycle consisting of denaturation at 94°C for 45 s, annealing
at 55 to 60°C for 30 s, and extension at 72°C for 60 s. The PCR
products were electrophoresed through agarose gels and visualized by ethidium bromide staining. The products were then isolated and ligated into the pGEM-T vector. DNA fragments were
released by Sac1 and Sma1, isolated, and ligated into pGL3 basic.
The resulting promoter-reporter constructs were purified using a
Qiagen-tip 500 column, according to the manufacturer's instructions, and the sequence was confirmed by dideoxy chain termination sequencing.
Cell Transfection
THP-1 cells (two million cells per condition) were transiently
transfected with 900 ng of the promoter-reporter construct and
100 ng of a pCMV-
-galactosidase plasmid (generously provided by Dr. Kenneth Chien, University of California, San Diego, San Diego, CA) using Effectene reagent (Qiagen, Chatsworth, CA).
The DNA:Effectene ratio was 1:10, and transfections were performed according to the manufacturer's instructions. Within each
experiment, pGL3 basic (as a negative control) and pGL3 control
(as a positive control) conditions were also performed. The cells
were incubated for 24 h at 37°C with 5% CO2 in RPMI 1640 medium containing 5% FCS. HeLa cells (two million cells per condition) were transiently transfected with 900 ng of the promoter-
reporter construct and 100 ng of a pCMV-
-galactosidase plasmid
using Lipofectin reagent (GIBCO), according to the manufacturer's instructions. The cells were incubated for 24 h at 37°C with
5% CO2 in MEM containing 5% FCS. Drosophila SL-2 cells (two
million cells per condition) were transiently transfected by calcium
phosphate precipitation, according to a previously described
method (19). DNA mixtures consisted of 5 µg of the promoter-
reporter construct and equimolar amounts of the Drosophila actin
promoter-driven expression vectors pPacSp1, pPacSp3, or pPac0 to
a total of 15 µg of DNA per condition (pPac0 and pPacSp1 were
generously provided by Dr. Robert Tjian, University of California,
Berkeley, Berkeley, CA; pPacSp3 was generously provided by
Dr. John D. Noti, Guthrie Research Institute; Sayre, PA). The cells
were incubated for 24 h at 25°C in Schneider's Drosophila medium
containing 10% FCS.
Reporter Gene Assays
Transfected cells were harvested and lysed with 100 µl of
Promega reporter lysis buffer (Promega, Madison, WI). After
centrifugation at 14,000 × g for 5 min, the supernatants were collected and assayed for luciferase and
-galactosidase activity. Luciferase activity was quantified using 50 to 90 µl of the lysate and
100 µl of Promega luciferase assay substrate (Promega), according to the manufacturer's instructions. Cell lysates were incubated at 48°C for 50 min to minimize endogenous
-galactosidase
activity.
-galactosidase activity was then quantified using 10 µl
of heat-treated lysate and the Tropix
-galactosidase assay system (Tropix, Bedford, MA), according to the manufacturer's instructions. Measurements were made using an Optocomp I luminometer (MGM Instruments, Hamden, CT). Luciferase activity
was normalized to
-galactosidase activity to account for variation in transfection efficiency.
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared from THP-1 and HeLa cells by a
previously described method (20). Electrophoretic mobility shift
assays (EMSAs) were performed using the Bandshift kit (Pharmacia Biotech, Piscataway, NJ), according to the manufacturer's
instructions. In brief, complementary single-stranded oligonucleotides from
56 to
17 bp of the promoter were synthesized and
annealed, yielding the LTCS-F1 double-stranded probe. The
LTCS-F1 probe was then labeled with [
-32P]adenosine triphosphate by polynucleotide kinase and incubated with 2 µl of 10 × binding buffer, 10 µg of bovine serum albumin, 1.6 µl of 50%
glycerol, 1.0 µg of poly (dI-dC), 0.5 µl of 200 mM ethylenediaminetetraacetic acid, 0.2 µl of 100 mM MgCl2, and 12 µg of
nuclear extract in a reaction volume of 20 µl. Where indicated,
reactions were supplemented with unlabeled, competitive oligonucleotide at a 30-fold molar excess. For supershift assays, 4 µg
of monoclonal anti-Sp1 and/or anti-Sp3 antibody were added 20 min after addition of the probe and the samples were incubated for an additional 30 min at 25°C. The samples were subjected to electrophoresis on a 4% nondenaturing polyacrylamide gel at 120 V for 2 h at 25°C. The gel was dried on a model 583 Gel Dryer (Bio-Rad, Hercules, CA) and exposed to autoradiographic film.
Site-Directed Mutagenesis of Promoter-Reporter Constructs
Site-directed mutagenesis of the p(
92)LUC and p(
1345)LUC
promoter-reporter constructs was performed by a PCR-based
strategy using the QuikChange Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA), according to the manufacturer's instructions. A 2-bp substitution of AA for CG at
38 and
39 bp
(relative to the transcription start site) was introduced within the
Sp1 consensus site to create the p(
92 Sp1 Mut)LUC and p(
1345
Sp1 Mut)LUC plasmids. Sequences of the mutated plasmids were
confirmed by dideoxy chain termination sequencing.
Materials
FCS, penicillin, streptomycin, and gentamicin were obtained from the Cell Culture Facility, University of California, San Diego. RPMI 1640 medium was obtained from BioWhittaker (Walkersville, MD). Schneider's Drosophila medium, agarose, and all restriction enzymes were obtained from GIBCO (Gaithersburg, MD). All synthesized oligonucleotides/primers were obtained from Cruachem (Dulles, VA). Autoradiographic film was purchased from Eastman Kodak Co. (Rochester, NY). Purified Sp1, anti-Sp1 antibody, and anti-Sp3 antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The pGEM-T, pGL3 basic, and pGL3 control vectors were obtained from Promega (Madison, WI). The Qiagen-tip 500 column was purchased from Qiagen (Chatsworth, CA). All other reagents were from Sigma Chemical (St. Louis, MO) and were of the finest grade available.
Data Analysis
Data are expressed as the mean ± SEM in all circumstances where mean values are compared. Data were analyzed by unpaired Student's t test (InStat, version 2.03, GraphPad Software, San Diego, CA). Differences were considered significant when P < 0.05.
| |
Results |
|---|
|
|
|---|
Functional Analysis of LTC4 Synthase Promoter-Reporter Gene Constructs
A serial deletion analysis was performed to determine the
functional significance of various regions of the LTC4 synthase promoter (Figure 1A). When screened for LTC4 synthase messenger RNA (mRNA) by RT-PCR, mRNA was
detected in THP-1 cells but not in HeLa cells (Figure 1B).
Transient transfection of THP-1 cells with promoter-reporter
constructs containing successive 5' deletions of the LTC4
synthase promoter demonstrated that the first 1.3 kb of the
promoter mediated a 21.1-fold increase in reporter activity above the basal level (4.65 ± 1.55 versus 0.22 ± 0.02% of
pGL3 control, respectively; mean ± standard error of the
mean [SEM]; n = 3; P < 0.001) (Figure 1C). Additionally,
the region between
92 and
23 bp (relative to the transcription start site) of the promoter mediated an 11.5-fold
increase in reporter activity above the basal level (2.54 ± 0.19 versus 0.22 ± 0.02 % of pGL3 control, respectively;
mean ± SEM; n = 3; P < 0.001) (Figure 1C). Transient transfection of HeLa cells with the LTC4 synthase promoter
deletion constructs demonstrated minimal levels of reporter
activity (Figure 1C). The lack of LTC4 synthase-driven
luciferase activity in HeLa cells could not be accounted for
by lower transfection efficiency because HeLa cells have
an approximately 6.5-fold higher transfection efficiency
than THP-1 cells, as measured by a luciferase assay using
transfection with a pGL3 control plasmid (20.7 × 105 versus 3.2 × 105 relative light units (RLU); mean ± SEM; n = 3). The relative luciferase activity was corrected by
cotransfection with a pCMV-
-galactosidase plasmid, and
all conditions are expressed as percentage of pGL3 control
(the positive control condition for each experiment).
|
Functional Analysis of LTC4 Synthase Promoter-Reporter
Gene Constructs between
92 and
23 bp
To further define the functional elements present in the
92
and
23 bp region of the LTC4 synthase promoter, a p(
51)
LUC promoter-reporter construct was prepared (Figure
2A). Transient transfection of THP-1 cells with the p(
92)
LUC, p(
51)LUC, and p(
23)LUC constructs demonstrated that the region between
92 and
51 bp could
account for 73% of the increase in reporter activity between
92 and
23 bp (Figure 2B). Additionally, the region between
51 and
23 bp, which contains an Sp1 consensus
site at
42 to
37 bp, could account for 27% of the reporter
activity between
92 and
23 bp (Figure 2B). We chose
to focus the remainder of our studies on the putative Sp1
site because this site appeared to be a prime candidate for a
locus of transcriptional control that mediated the increase
in reporter activity observed with the inclusion of the
92 and
23 bp promoter region in promoter-reporter constructs.
|
Effect of Mutation of the Sp1 Binding Site on Function of LTC4 Synthase Promoter-Reporter Constructs
To examine the functional significance of the Sp1 consensus
site, transient transfection of THP-1 cells with either wild-type p(
1345)LUC or p(
92)LUC, or mutated p(
1345
Sp1 Mut)LUC or p(
92 Sp1 Mut)LUC promoter-reporter
constructs was performed (Figure 3A). The results demonstrated that mutation of the Sp1 site (AA for CG substitution at
38 and
39 bp) in the p(
1345)LUC construct resulted in a substantial decrease in reporter activity (Figure 3B). Similarly, mutation of the Sp1 site in the p(
92)LUC
construct resulted in a significant decrease in reporter activity,
close to the basal level (Figure 3B). The findings indicate
that the Sp1 consensus site functions as a critical positive
regulatory element.
|
EMSA of Sp1 Binding Site Sequences
To determine if transcription factors bind to the Sp1 consensus site, EMSAs were performed using the double-stranded LTC4 synthase fragment 1 (LTCS-F1) oligonucleotide probe incubated with nuclear extract from THP-1 or HeLa cells or purified Sp1 (Figure 4A). In the presence of purified Sp1, a single gel-shifted band (band 1) was observed, indicating that Sp1 binds to this region of the promoter (Figure 4B). EMSA performed in the presence of THP-1 nuclear extract demonstrated a pattern consisting of two upper bands (bands 1 and 2) and one lower band (band 3) (Figure 4B). A similar banding pattern was observed in the EMSA in the presence of HeLa nuclear extract (Figure 4B).
|
Supershift EMSA of Sp1 Binding Site Sequences
To specifically determine if Sp family members bind to the putative Sp1 site, EMSAs were performed using the LTCS-F1 oligonucleotide probe with nuclear extract from THP-1 cells and antibodies against Sp family members (Figure 4B). In the presence of THP-1 nuclear extract and anti-Sp1 antibody, band 1 was competitively inhibited and supershifted. In the presence of THP-1 nuclear extract and anti-Sp3 antibody, bands 2 and 3 were competitively inhibited and supershifted. In the presence of THP-1 nuclear extract and both anti-Sp1 and anti-Sp3 antibodies, bands 1, 2, and 3 were competitively inhibited and supershifted, indicating that the gel-shifted bands are due to both Sp1 and Sp3 (Figure 4B). Supershift EMSAs performed in the presence of HeLa nuclear extract demonstrated similar results (Figure 4B).
EMSA of Mutant Sp1 Binding Site Sequences
To determine the key elements required for Sp1 and Sp3 binding, EMSAs were performed with either wild-type LTCS-F1 probe (LTCS-F1) or a probe containing a mutation of the Sp1 site (LTCS-F1 MUT) incubated with THP-1 nuclear extract or purified Sp1 (Figure 4B). Mutation of the Sp1 site resulted in elimination of the binding of both purified Sp1 and THP-1 nuclear extract (Figure 4B), confirming this site as the locus of transcription factor binding.
Drosophila SL-2 Transfection Studies
To determine the exact functional significance of the Sp1
site, transient cotransfection of Sp-deficient Drosophila
SL-2 cells with the p(
92)LUC promoter-reporter construct and Sp family member expression constructs was
performed. In the presence of either pPacSp1 or pPacSp3
expression constructs, reporter activity was significantly
increased (Figure 5), indicating that both Sp1 and Sp3 are
capable of positively regulating LTC4 synthase gene transcription. Mutation of the Sp1 site (a 2-bp substitution) resulted in a diminution of the stimulatory effect on transcription (Figure 5), supporting the positive regulatory
role for Sp1 and Sp3 acting through the Sp1 site.
|
| |
Discussion |
|---|
|
|
|---|
In this report, we demonstrate evidence that expression of
the LTC4 synthase gene is transcriptionally regulated in
mononuclear phagocytes. We report a deletion analysis of
the gene promoter and we demonstrate that the first 1.3 kb
of the LTC4 synthase promoter mediates a 21.1-fold increase in transcriptional activity in the monocyte-like cell
line THP-1. We also present evidence that the promoter
region from
92 to
23 bp (relative to the transcription start site) mediates an 11.5-fold increase in promoter activity over the basal level observed with the minimal promoter (represented by the first 23 bp of the promoter).
This increase in promoter activity is specific to the THP-1
cell line as promoter activity is observed to be minimal in
the HeLa cell line, which is of epithelial origin. We demonstrate that a proximal promoter Sp1 consensus site, located at
42 to
37 bp, is an important regulatory element that is necessary for promoter activity. Moreover, we
identify Sp1 and Sp3 as the transcription factors that bind
to this promoter element. Finally, our findings indicate
that Sp1 and Sp3 function to transactivate LTC4 synthase
gene transcription through this Sp1 consensus site.
The mechanism of regulation of constitutive and induced LTC4 synthase gene expression is largely unknown.
Although previous studies have investigated the regulation
of expression of enzymatic activity by various cytokines in
complex conditioning experiments (14, 15), the molecular
mechanism of action of these agents is unclear. A recent
study from our laboratory demonstrated that TGF-
upregulated the mRNA for LTC4 synthase in THP-1 cells
through enhanced gene transcription but not through prolonged mRNA half-life (16). The current study was performed to begin to investigate the regulation of this important
gene. Our findings indicate the existence of positive regulatory elements within the
92 to
23 bp promoter region
as well as within the further upstream regions of the first
1.3 kb of the promoter. None of the constructs demonstrate any significant reporter activity in the HeLa cell line,
which is of epithelial origin and does not express LTC4
synthase mRNA. These data indicate that LTC4 synthase
promoter activity is inflammatory cell-specific. The LTC4
synthase promoter lacks a TATA box but is known to
possess putative binding sites for ets, AP-1, AP-2, and Sp1
transcription factors. Notably, the region of the LTC4 synthase gene promoter from
92 to
23 bp, which contains
a characteristic high affinity Sp1 binding site (GGGCGG)
at
42 to
37 bp, mediates an 11.5-fold increase in reporter activity. Our data provide substantial evidence that
this segment of the promoter functions to positively regulate gene expression through the binding of Sp transcription factor family members.
The Sp family of transcription factors, four of which have been described and characterized (21, 22), is widely expressed and modulates the expression of a large variety of genes. The transcription factor Sp1 was first identified by its ability to activate the SV40 early promoter by binding to a tandem repeat of GC-rich sequences, termed "GC boxes" (22). The family members Sp3 and Sp4 recognize GC boxes with a similar affinity to that of Sp1, whereas Sp2 exhibits significantly lower binding affinity (21). Sp1 and Sp3 are known to be widely expressed in mammalian cell lines, whereas Sp4 expression is limited to certain cells of the brain (23). Sp family member consensus sites are frequently observed sites of regulation of TATA-less genes and are often located in proximity to the transcription start site, providing a potential interaction with components of the transcription initiation complex (24, 25). The proximal location of the Sp1 site in the LTC4 synthase promoter suggests this type of interaction as a possible mechanism in the regulation of transcription.
We specifically demonstrated that the Sp1 consensus
site (at
42 to
37 bp) is an essential element for LTC4
synthase promoter activity. Although inclusion of the site
accounts for a modest 3.3-fold increase in promoter activity (as compared with the activity of the minimal promoter), its absence from the construct containing the first
92 bp of the promoter results in a substantial decrement in
activity, approaching the basal level. Similarly, assessment of the reporter activity of the construct containing the first 1.3 kb of the promoter with a mutation of the Sp1 site likewise demonstrates a notable decrement in function. These
findings support a crucial role of the Sp1 site in the transcriptional regulation of this gene. Sp1 consensus sites
have been demonstrated to possess such potent and essential regulatory roles in the transcription of other previously described genes (26, 27).
Our findings indicate that Sp1 and Sp3, which are present in THP-1 and HeLa nuclear extracts, bind to the LTC4 synthase promoter in the region that contains the Sp1 consensus site. In addition, we demonstrated that mutation of the Sp1 site prevents any transcription factor binding, suggesting that this site is the only element that binds Sp family members in this region. The differential regulation of gene expression by such ubiquitously expressed transcription factors (such as Sp1 and Sp3) can be effected by the modulation of factor synthesis and availability. Although our data do not specifically quantify the transcription factors present, the results clearly indicate that Sp1 and Sp3 are both present in THP-1 and HeLa nuclear extracts. The cell-specific expression of LTC4 synthase could also be influenced by the post-translational modification of Sp1, such as by phosphorylation or glycosylation events (28, 29), which may regulate activity of the transcription factor. Higher phosphorylation levels of Sp1 have been reported in myeloid cells, as compared with epithelial cells (30), but the phosphorylation of Sp family members is likely not a significant regulatory mechanism in monocytes. Although the competition of Sp1 with other factors for the consensus binding site may result in cell-specific gene expression, our findings do not provide evidence of such competition occurring at the Sp1 site, as only Sp1 and Sp3 were found to bind to this promoter element.
Deletion analysis data reveal an increment in reporter
activity with inclusion of the
92 to
51 bp region of the
promoter, raising the possibility of transcription factor
binding to this region as well. However, database analysis
identifies no known consensus sites within this region. The
above finding does not diminish the critical role of the Sp1
consensus site in the transcription of the LTC4 synthase
gene. It does, however, raise the possibility of a protein-
protein interaction between an Sp family member (binding at the
42 to
37 bp site) and an unknown transcription factor binding at an upstream site (namely, to the
92
to
51 bp region). Previous studies support such a contention,
as Sp family member consensus sites are frequently located in proximity to binding sites for other transcription
factors, such as Egr-1 (31). Such proximity may allow for
interaction between factors and resultant synergistic effects
on transcription, possibly through the stabilization of binding
or the exposure of binding domains. This latter type of
synergism has been previously reported to occur in the interaction between Sp family members (32) and could potentially
play a role in cell-specific gene expression. These previous
findings are therefore consistent with our data. Whereas
the Sp1 site in the proximal LTC4 synthase promoter appears to be crucial for expression, it does not appear to be sufficient for cell-specific expression in and of itself. In this respect, although both THP-1 and HeLa cells possess Sp1 and Sp3,
which bind to the Sp1 site, we propose that the interaction
of Sp family members with other factors may result in cell-specific expression of the LTC4 synthase gene.
Our findings in the Sp-deficient Drosophila SL-2 cell
line indicate that both Sp1 and Sp3 are positive regulators
of LTC4 synthase gene transcription, suggesting a cooperative role of these factors. Functionally, Sp1 has been described to act as a repressor (33) or activator of gene transcription. Similarly, Sp3 has been demonstrated to act as a
bifunctional regulator of transcription with both activator
and repressor domains (27). Previous reports suggest that
Sp3 may function in an antagonistic (34) or synergistic (35)
manner with Sp1, depending on the particular gene involved and the local cellular milieu. In addition, previous
studies of the acetylcholine receptor
4 subunit gene provide evidence that Sp1 and Sp3 may simultaneously bind to
the same promoter element and directly interact with each
other to enhance gene transcription (35). Our current findings are, therefore, consistent with the previously reported
roles of Sp1 and Sp3 in the regulation of gene transcription.
In summary, we demonstrated that expression of the
LTC4 synthase gene is transcriptionally regulated by Sp
family members in THP-1 cells. We demonstrated that this
upregulation is dependent on the proximal promoter Sp1
site located at
42 to
37 bp. Although our findings do not
exclude the interaction of factors binding at other upstream
sites with Sp family members, our results indicate that this Sp1
site is an important element involved in gene transcription. We also demonstrated that both Sp1 and Sp3 bind to this
site and function as positive regulators of transcription of the
LTC4 synthase gene. Our data provide convincing evidence
that expression of this important gene is cell-specific and
transcriptionally regulated in mononuclear phagocytes.
| |
Footnotes |
|---|
Abbreviations: electrophoretic mobility shift assay, EMSA; fetal calf serum, FCS; granulocyte-macrophage colony-stimulating factor, GM-CSF; interleukin, IL; leukotriene, LT; LTC4 synthase fragment 1, LTCS-F1; luciferase, LUC; Eagle's minimum essential medium, MEM; messenger RNA, mRNA; polymerase chain reaction, PCR; reverse transcriptase/polymerase chain reaction, RT-PCR; signal protein, Sp; transforming growth factor, TGF.
(Received in original form December 2, 1999 and in revised form March 28, 2000).
Acknowledgments: This work was supported by grant 7RT-0097 from the University of California Tobacco-Related Disease Research Program (T.D.B.), a grant from the Merit Review Board of the Department of Veterans Affairs (T.D.B.), a Research Training Fellowship Award from the American Lung Association of California (K.J.S.), and an Allen & Hanburys' Career Investigator Award from the American Lung Association (T.D.B.).
| |
References |
|---|
|
|
|---|
1. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323: 645-655 [Medline].
2. Namovic, M. T., R. E. Walsh, C. Goodfellow, R. R. Harris, G. W. Carter, and R. L. Bell. 1996. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats. Eur. J. Pharmacol. 315: 81-88 [Medline].
3. Israel, E., R. Dermakarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323: 1740-1744 [Abstract].
4. Makker, H. K., L. C. Lau, H. W. Thomson, S. M. Binks, and S. T. Holgate. 1993. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am. Rev. Respir. Dis. 147: 1413-1418 [Medline].
5.
Jakobsson, P. J.,
J. A. Mancini, and
A. W. Ford-Hutchinson.
1996.
Identification and characterization of a novel human microsomal glutathione
S-transferase with leukotriene C4 synthase activity and significant sequence
identity to 5-lipoxygenase activating protein and leukotriene C4 synthase.
J. Biol. Chem.
271:
22203-22210
6. Bigby, T. D., and N. Meslier. 1989. Transcellular metabolism between monocytes and platelets. J. Immunol. 143: 1948-1954 [Abstract].
7. Cowburn, A. S., K. Sladek, J. Soja, L. Adamek, E. Nizankowska, A. Szczeklik, B. K. Lam, J. F. Penrose, K. F. Austen, S. T. Holgate, and A. P. Sampson. 1997. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101: 834-846 [Medline].
8. Bigby, T. D., C. R. Hodulik, K. C. Arden, and L. Fu. 1996. Molecular cloning of the human leukotriene C4 synthase gene and assignment to chromosome 5q35. Mol. Med. 2: 637-646 [Medline].
9.
Penrose, J. F.,
J. Spector,
M. Baldasaro,
K. Xu,
J. Boyce,
J. P. Arm,
K. F. Austen, and
B. K. Lam.
1996.
Molecular cloning of the gene for human
leukotriene C4 synthase: organization, nucleotide sequence, and chromosomal localization to 5q35.
J. Biol. Chem.
271:
11356-11361
10. Kargman, S., A. Ali, J. P. Vaillancourt, J. F. Evans, and D. W. Nicholson. 1994. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells. Mol. Pharmacol. 45: 1043-1049 [Abstract].
11. Ali, A., A. W. Ford-Hutchinson, and D. W. Nicholson. 1994. Activation of protein kinase C down-regulates leukotriene C4 synthase activity and attenuates cysteinyl leukotriene production in an eosinophilic substrain of HL-60 cells. J. Immunol. 153: 776-788 [Abstract].
12. Tornhamre, S., C. Edenius, and J. Lindgren. 1995. Receptor-mediated regulation of leukotriene C4 synthase activity in human platelets. Eur. J. Biochem. 234: 513-520 [Medline].
13. Sjolinder, M., S. Tornhamre, P. Werga, C. Edenius, and J. A. Lindgren. 1995. Phorbol ester-induced suppression of leukotriene C4 synthase activity in human granulocytes. FEBS Lett. 377: 87-91 [Medline].
14.
Murakami, M.,
K. F. Austen,
C. O. I. Bingham,
D. S. Friend,
J. F. Penrose, and
J. F. Arm.
1995.
Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells.
J. Biol.
Chem.
270:
22653-22656
15.
Scoggan, K. A.,
A. W. Ford-Hutchinson, and
D. W. Nicholson.
1995.
Differential activation of leukotriene biosynthesis by granulocyte-macrophage
colony stimulating factor and interleukin-5 in an eosinophilic substrain of
HL-60 cells.
Blood
86:
3507-3516
16.
Riddick, C. A.,
K. J. Serio,
C. R. Hodulik,
W. L. Ring,
M. S. Regan, and
T. D. Bigby.
1999.
TGF-
increases leukotriene C4 synthase expression in
the monocyte-like cell line, THP-1.
J. Immunol.
162:
1102-1107
.
17. Riddick, C. A., W. L. Ring, J. R. Baker, C. R. Hodulik, and T. D. Bigby. 1997. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246: 112-118 [Medline].
18. Ausbel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1992. Current Protocols in Molecular Biology. Greene Publishing Association and John Wiley and Sons, Brooklyn, NY.
19.
Di Nocera, P. P., and
I. B. Dawid.
1983.
Transient expression of genes introduced into cultured cells of Drosophila.
Proc. Natl. Acad. Sci. USA
80:
7095-7098
20.
Dignam, J. D.,
R. M. Lebovitz, and
R. G. Roeder.
1983.
Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian
nuclei.
Nucleic Acids Res.
11:
1475-1489
21.
Kingsley, C., and
A. Winoto.
1992.
Cloning of GT binding proteins: a novel
Sp1 multigene family regulating T-cell receptor gene expression.
Mol.
Cell. Biol.
12:
4251-4261
22. Kadonaga, J. T., K. R. Carner, F. R. Marsiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090 [Medline].
23.
Hagen, G.,
S. Muller,
M. Beato, and
G. Suske.
1992.
Cloning by recognition
site screening of two novel GT box binding proteins: a family of Sp1 related genes.
Nucleic Acids Res.
20:
5519-5525
24. Hoey, T., R. O. J. Weinzierl, G. Gill, J. -L. Chen, B. D. Dynlacht, and R. Tjian. 1993. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72:247-260.
25.
Majello, B.,
P. De Luca, and
L. Lania.
1997.
Sp3 is a bifunctional regulator
with modular independent activation and repression domains.
J. Biol.
Chem.
272:
4021-4026
26.
Hauses, M.,
R. R. Tonjes, and
M. Grez.
1998.
The transcription factor Sp1
regulates the myeloid-specific expression of the human hematopoietic cell
kinase (HCK) gene through binding to two adjacent GC boxes within the
HCK promoter-proximal region.
J. Biol. Chem.
273:
31844-31852
27.
Shou, Y.,
S. Baron, and
M. Poncz.
1998.
An Sp1-binding silencer element is
a critical negative regulator of the megakaryocyte-specific
IIb gene.
J. Biol.
Chem.
273:
5716-5726
28.
Black, A. R.,
D. Jensen,
S. Lin, and
J. C. Azizkhan.
1999.
Growth/cell cycle
regulation of Sp1 phosphorylation.
J. Biol. Chem
274:
1207-1215
29. Han, I., and J. E. Kudlow. 1997. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17: 2550-2558 [Abstract].
30.
Zhang, D. E.,
C. J. Hetherington,
S. Tan,
S. E. Dziennis,
D. A. Gonzalez,
H. M. Chen, and
D. G. Tenen.
1994.
Sp1 is a critical factor for the monocytic specific expression of human CD14.
J. Biol. Chem.
269:
11425-11434
31.
Ebert, S. N., and
D. L. Wong.
1995.
Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1.
J. Biol.
Chem.
270:
17299-17305
32.
Hagen, G.,
J. Dennig,
A. Preiss,
M. Beato, and
G. Suske.
1995.
Functional
analyses of the transcription factor Sp4 properties distinct from Sp1 and
Sp3.
J. Biol. Chem.
270:
24989-24994
33.
Li, R.,
Z. Hodny,
K. Luciakova,
P. Barath, and
B. D. Nelson.
1996.
Sp1 activates and inhibits transcription from separate elements in the proximal
promoter of the human adenine nucleotide translocase 2 (ANT2) gene.
J. Biol.
Chem.
271:
18925-18930
34.
Majello, B.,
P. De Luca,
G. Hagen,
G. Suske, and
L. Lania.
1994.
Different
members of the Sp1 multigene family exert opposite transcriptional regulation of the long-terminal repeat of HIV-1.
Nucleic Acids Res.
22:
4914-4921
35.
Bigger, C. B.,
I. N. Melnikova, and
P. D. Gardner.
1997.
Sp1 and Sp3 regulate expression of the neuronal nicotinic acetycholine receptor
4 subunit
gene.
J. Biol. Chem.
272:
25976-25982
This article has been cited by other articles:
![]() |
K. J. Serio, C. Luo, L. Luo, and J. T. Mao TNF-{alpha} downregulates the leukotriene C4 synthase gene in mononuclear phagocytes Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L215 - L222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Serio, K. V. Reddy, and T. D. Bigby Lipopolysaccharide induces 5-lipoxygenase-activating protein gene expression in THP-1 cells via a NF-{kappa}B and C/EBP-mediated mechanism Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1125 - C1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Dwyer, H. Allayee, K. M. Dwyer, J. Fan, H. Wu, R. Mar, A. J. Lusis, and M. Mehrabian Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis N. Engl. J. Med., January 1, 2004; 350(1): 29 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Sayers, S Barton, S Rorke, B Beghe, B Hayward, P Van Eerdewegh, T Keith, J B Clough, S Ye, J W Holloway, et al. Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma Thorax, May 1, 2003; 58(5): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Reddy, K. J. Serio, C. R. Hodulik, and T. D. Bigby 5-Lipoxygenase-activating Protein Gene Expression. KEY ROLE OF CCAAT/ENHANCER-BINDING PROTEINS (C/EBP) IN CONSTITUTIVE AND TUMOR NECROSIS FACTOR (TNF) alpha -INDUCED EXPRESSION IN THP-1 CELLS J. Biol. Chem., April 11, 2003; 278(16): 13810 - 13818. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Serio, S. C. Johns, L. Luo, C. R. Hodulik, and T. D. Bigby Lipopolysaccharide Down-Regulates the Leukotriene C4 Synthase Gene in the Monocyte-Like Cell Line, THP-1 J. Immunol., February 15, 2003; 170(4): 2121 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Rao, S. Maiti, H. N. Ananthaswamy, and M. F. Wilkinson A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell Types J. Biol. Chem., July 12, 2002; 277(29): 26036 - 26045. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Bigby The Leukotriene C4 Synthase Gene and Asthma Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 273 - 276. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |